What Intelon Optics does

Intelon Optics is a privately-held medical device company that develops and commercializes the Brillouin Optical Scanning System (BOSS), a non-contact optical platform that uses Brillouin light-scattering to measure tissue biomechanics (stiffness, elasticity, viscosity) in real-time, high-resolution 3D. The company was founded circa 2018 and is headquartered in Woburn, Massachusetts, with a workforce of 11-50 employees. Its flagship product, BOSS EYE, is the first FDA-cleared and CE-marked Brillouin-based ophthalmic scanner, designed to image the cornea and crystalline lens and measure their intrinsic elastic properties without macroscopic stimulation, addressing limitations of existing tools such as ORA and CorVis that provide only indirect approximations. The product portfolio also includes BOSS LS (a research-grade Brillouin microscope for cellular and tissue biomechanics, available as a standalone system or add-on for inverted microscopes), BOSS IVF (an investigational platform for reproductive cell biomechanics), and BOSS AI (an analytics module for treatment planning).

The company sells primarily through enterprise field sales targeting refractive surgeons, corneal specialists, and academic medical centers, supported by participation at major international ophthalmology conferences (ASCRS, ARVO, ESCRS, AAO, World Keratoconus Congress, KCXL) and Key Opinion Leader engagement. Revenue is generated from hardware sales of BOSS systems to eye clinics, hospitals, and refractive surgery centers, supplemented by post-sale service and support. Distribution combines direct sales with a global distributor network. The company holds regulatory approvals in the United States (FDA 510(k) clearance, September 2024), the European Union (CE mark, February 2021), Canada (Health Canada, November 2021), and South Korea (May 2021), with ISO 13485:2016 quality certification maintained. Visible named customers include Moorfields Eye Hospital (UK), Bordeaux Hospital & University (France), University Eye Clinic Heidelberg (Germany), Woolfson Eye Institute (US), Resbiomed (Bulgaria), Fatima Eye Clinic (South Korea), and Umeå University Hospital (Sweden).

The company has raised approximately $6.78M across two funding rounds (2017 and 2018) and remains privately held without disclosed external controlling investors. Management includes CEO Lawrence Yoo PhD, COO Dimitri Chernyak PhD, CFO Jeffrey Choi, and CLO Joseph Chu JD, with technical advisory from Harvard Medical School and University of Maryland faculty. Its competitive position rests on first-mover regulatory advantage in Brillouin-based ocular biomechanics, a body of 45+ peer-reviewed publications validating clinical use cases, and clinical evidence showing that BOSS biomechanics data improved refractive surgery planning outcomes (patients within ±1.0D increased from 81% to 96%; within ±1.5D increased from 90% to 100% in referenced studies).

Name

Intelon Optics

Legal name

Intelon Optics Inc.

Website

https://intelon.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Intelon Optics develops the Brillouin Optical Scanning System (BOSS), a non-contact optical platform for measuring tissue biomechanics. Its FDA-cleared BOSS EYE scanner serves ophthalmologists, refractive surgeons, and academic medical centers, with research platforms extending into life sciences and IVF.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Ophthalmic Goods Manufacturing (339115)

SIC

Optical Instruments & Lenses (3827), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Refractive Diagnostics & Biometry (Autorefractors, Keratometers, Topography/Tomography, A-Scan/Optical Biometry) (HLAHAJAA)

akta.pro secondary industries

Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF), Glaucoma Diagnostics & Surgical Devices (Tonometry, Gonioscopy, MIGS, Drainage Implants, Laser Trabeculoplasty) (HLAHAJAI), Vision & Ophthalmic Diagnostic Centers (Optometry/OCT/Retinal Imaging) (HLAFAKAI)

Keywords

• Brillouin optical scanning
• Ophthalmic medical devices
• Corneal biomechanics
• Non-contact tissue imaging
• Refractive surgery diagnostics

Headquarters

HQ city

Lexington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Medical Device Hardware Sales: Sale of BOSS ophthalmic devices (BOSS EYE) to eye clinics, hospitals, and refractive surgery centers. The system is FDA-cleared and commercially available for orders. Revenue generated from initial hardware purchase.
2. Service and Support: Ongoing service, maintenance, and support for installed BOSS systems. VP of Manufacturing and Service (Dann Diaz) indicates post-sale service operations.
3. Research Collaborations (BOSS IVF & LS): BOSS LS and BOSS IVF are research-stage platforms. Intelon Optics collaborates with academic, clinical, and industrial laboratories for exploratory research, potentially generating revenue through system sales and research partnerships.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Intelon Optics develops and commercializes the Brillouin Optical Scanning System (BOSS), a non-contact optical scanning platform that uses Brillouin light-scattering to measure ocular and cellular tissue biomechanics in real-time, high-resolution 3D. Its flagship BOSS EYE is the first FDA-cleared and CE-marked Brillouin ophthalmic scanner, used clinically for corneal and crystalline lens assessment in refractive surgery and keratoconus evaluation. The platform also extends to research applications via BOSS LS (life sciences microscope) and BOSS IVF (reproductive cell research).

Product overview

Intelon Optics develops the Brillouin Optical Scanning System (BOSS) platform, a portfolio of medical devices spanning ophthalmology, life sciences research, and reproductive biology. The core BOSS platform uses proprietary Brillouin light-scattering technology to measure tissue biomechanics (stiffness, elasticity, viscosity) non-contact via optical scanning. BOSS EYE is the FDA-cleared and CE-marked ophthalmology product for clinical use in imaging cornea and crystalline lens. BOSS LS extends the platform as a research microscope for life science laboratories. BOSS IVF is an investigational research tool for IVF/reproductive biology applications. The BOSS AI module provides data analytics capabilities for the ophthalmology system. All products share the underlying Brillouin optical scanning technology while serving different market segments (clinical, research) and anatomical applications (eye, cells/tissues, reproductive cells).

Differentiator

Problem solved

Functional benefit

Brands

• BOSS® EYE: FDA-cleared and CE-marked Brillouin non-contact ophthalmic scanner for imaging cornea and crystalline lens and measuring elastic properties of ocular tissues.
• BOSS® LS
• BOSS® IVF
• BOSS® AI

Products and services

• BOSS EYE (Ophthalmology) First commercially available FDA-cleared and CE-marked Brillouin non-contact ophthalmic scanner that measures ocular-tissue biomechanics in real-time, high-resolution 3D. Enables fast, non-contact automated optical scanning of the cornea and crystalline lens, providing intrinsic biomechanical data to complement traditional OCT and topography tools. Targeted at refractive surgeons, corneal specialists, eye clinics, and academic medical centers for refractive surgery planning, keratoconus screening, ectasia risk assessment, and crystalline lens elasticity evaluation.
• BOSS LS (Life Sciences) World's first Brillouin-based scanning microscope available for laboratory use, providing non-contact, label-free, sub-micron spatial resolution 3D imaging with direct assessment of biomechanics (stiffness and viscosity). Available as a standalone system or as a custom add-on module for most major inverted microscopes, enabling integration into existing microscopy workflows. Targeted at academic and industrial researchers in cellular biomechanics, cancer cell biology, stem cell research, mechanobiology, and drug discovery.
• BOSS IVF (In Vitro Fertilization) Next-generation research platform using Brillouin light-scattering technology to visualize viscoelastic behavior of oocytes, embryos, and sperm via non-contact, dye-free, label-free optical measurement that captures micro-scale biomechanical information without physical probes. Designed for integration with laboratory incubators and time-lapse imaging systems. Targeted at IVF clinics and reproductive biology researchers investigating gamete and embryo biomechanics to complement morphological assessment.

Quantifiable outcome

• In refractive surgery planning, BOSS biomechanics data reduced patients within ±1.0D from 81% to 96% (revision surgery rate reduction)
• +2 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

One partnership is on record.

• Vold VisionnotableStrategic or Co-development Partner · 18 August 2021Intelon partnered with Vold Vision, indicating a commercial partnership for introducing BOSS technology to the market. Vold Vision is an eye care practice that began offering BOSS scanning to patients.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Oculus (Pentacam, Corvis ST): Oculus manufactures the Pentacam anterior segment tomographer and the Corvis ST, a non-contact tonometer with corneal biomechanics visualization. Both compete directly with BOSS EYE in refractive surgery screening and corneal biomechanics assessment.
• Reichert Technologies: Reichert makes the Ocular Response Analyzer (ORA), the most widely deployed clinical corneal biomechanics device. ORA and BOSS address the same clinical use cases (LASIK screening, keratoconus detection, ectasia risk) with overlapping ophthalmology customer bases.
• Ziemer Ophthalmic Systems: Ziemer develops femtosecond laser systems for refractive surgery (e.g., FEMTO LDV Z8) and adjacent corneal diagnostics. Its customer base in refractive surgery centers overlaps directly with BOSS EYE's primary commercial targets.

Broad incumbents

• Heidelberg Engineering: Heidelberg Engineering is the parent of Oculus (Pentacam, Corvis ST) and a leading ophthalmic imaging incumbent with SPECTRALIS OCT. It competes broadly in anterior and posterior segment diagnostics sold into the same refractive and academic eye centers as Intelon.
• Carl Zeiss Meditec: Carl Zeiss Meditec offers CIRRUS HD-OCT, Humphrey perimeters, and a broad refractive surgery portfolio. It sells comprehensive ophthalmic diagnostic ecosystems into the same eye hospitals and academic centers that are BOSS reference accounts.
• Nidek: Nidek manufactures a wide range of ophthalmic diagnostic devices including the OPD-Scan III aberrometer and corneal topographers. Its portfolio overlaps with BOSS in refractive surgery clinics and optometry/ophthalmology offices globally.
• Topcon Healthcare: Topcon Healthcare produces anterior segment imaging, OCT, and corneal diagnostic devices sold to eye care professionals worldwide. Its installed base in optometry and ophthalmology overlaps with Intelon's target customer segments.
• Bausch + Lomb: Bausch + Lomb is a broad ophthalmic incumbent covering cataract, refractive, and vision-care products, with established distribution into refractive surgery centers and optometry offices that BOSS targets.
• Alcon: Alcon is one of the largest global ophthalmic device and surgical companies, with cataract, refractive, and diagnostic portfolios that overlap with the customer ecosystem Intelon sells into (refractive surgeons, eye hospitals, ambulatory surgery centers).

Emerging players

• i-Optics: i-Optics is a smaller ophthalmic diagnostics company known for Cassini corneal topography and EasyScan retinal imaging. It targets similar niche clinical adoption pathways as BOSS within refractive and anterior segment practices.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Intelon_Optics
• Facebookfacebook.com/IntelonOptics-104787611537939

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds2 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intelon Optics